Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KORU Medical Systems (KRMD) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for KORU Medical Systems (KRMD) over the last 10 years, with Q3 2025 value amounting to $27.1 million.

  • KORU Medical Systems' Liabilities and Shareholders Equity fell 104.6% to $27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.1 million, marking a year-over-year decrease of 325.39%. This contributed to the annual value of $27.2 million for FY2024, which is 436.55% down from last year.
  • Per KORU Medical Systems' latest filing, its Liabilities and Shareholders Equity stood at $27.1 million for Q3 2025, which was down 104.6% from $25.5 million recorded in Q2 2025.
  • KORU Medical Systems' 5-year Liabilities and Shareholders Equity high stood at $43.4 million for Q1 2022, and its period low was $25.5 million during Q2 2025.
  • For the 5-year period, KORU Medical Systems' Liabilities and Shareholders Equity averaged around $34.9 million, with its median value being $36.0 million (2023).
  • Per our database at Business Quant, KORU Medical Systems' Liabilities and Shareholders Equity soared by 458.74% in 2022 and then crashed by 3276.79% in 2023.
  • Quarter analysis of 5 years shows KORU Medical Systems' Liabilities and Shareholders Equity stood at $41.3 million in 2021, then rose by 2.52% to $42.3 million in 2022, then crashed by 32.77% to $28.5 million in 2023, then dropped by 4.37% to $27.2 million in 2024, then fell by 0.42% to $27.1 million in 2025.
  • Its Liabilities and Shareholders Equity was $27.1 million in Q3 2025, compared to $25.5 million in Q2 2025 and $27.2 million in Q1 2025.